Computational design and engineering of self-assembling multivalent microproteins with therapeutic potential against SARS-CoV-2
Description
Multivalent drugs targeting homo-oligomeric viral surface proteins, such as the SARS-CoV-2 trimeric spike (S) protein, have the potential to elicit more potent and broad-spectrum therapeutic responses than monovalent drugs by synergistically engaging